|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN, 2012. Int J cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jeon SY, Hwang KA and Choi KC: Effect of
steroid hormones, estrogen and progesterone, on epithelial
mesenchymal transition in ovarian cancer development. J Steroid
Biochem Mol Biol. 158:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim A, Ueda Y, Naka T and Enomoto T:
Therapeutic strategies in epithelial ovarian cancer. J Exp Clin
Cancer Res. 31:142012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang P, Zhang P, Shi B, Zhou M, Jiang H,
Zhang H, Pan X, Gao H, Sun H and Li Z: Galectin-1 overexpression
promotes progression and chemoresistance to cisplatin in epithelial
ovarian cancer. Cell Death Dis. 5:e9912014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu J, Zheng Y, Zhang H, Zhu J and Sun H:
Low concentration of chloroquine enhanced efficacy of cisplatin in
the treatment of human ovarian cancer dependent on autophagy. Am J
Transl Res. 9:4046–4058. 2017.PubMed/NCBI
|
|
6
|
Maurmann L, Belkacemi L, Adams NR,
Majmudar PM, Moghaddas S and Bose RN: A novel cisplatin mediated
apoptosis pathway is associated with acid sphingomyelinase and FAS
proapoptotic protein activation in ovarian cancer. Apoptosis.
20:960–974. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cornelison R, Llaneza DC and Landen CN:
Emerging therapeutics to overcome chemoresistance in epithelial
ovarian cancer: A mini-review. Int J Mol Sci. 18:E21712017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren F, Shen J, Shi H, Hornicek FJ, Kan Q
and Duan Z: Novel mechanisms and approaches to overcome multidrug
resistance in the treatment of ovarian cancer. Biochim Biophys
Acta. 1866:266–275. 2016.PubMed/NCBI
|
|
9
|
Lou JS, Bi WC, Chan GKL, Jin Y, Wong CW,
Zhou ZY, Wang HY, Yao P, Dong TTX and Tsim KWK: Ginkgetin induces
autophagic cell death through p62/SQSTM1-mediated autolysosome
formation and redox setting in non-small cell lung cancer.
Oncotarget. 8:93131–93148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naik PP, Mukhopadhyay S, Panda PK, Sinha
N, Das CK, Mishra R, Patil S and Bhutia SK: Autophagy regulates
cisplatin-induced stemness and chemoresistance via the upregulation
of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma. Cell
Prolif. 51:2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pistollato F, Calderón Iglesias R, Ruiz R,
Aparicio S, Crespo J, Dzul Lopez L, Giampieri F and Battino M: The
use of natural compounds for the targeting and chemoprevention of
ovarian cancer. Cancer Lett. 14:191–200. 2017. View Article : Google Scholar
|
|
12
|
Zhou WJ, Chang KK, Wu K, Yang HL, Mei J,
Xie F, Li DJ and Li MQ: Rapamycin synergizes with cisplatin in
antiendometrial cancer activation by improving IL-27-stimulated
cytotoxicity of NK cells. Neoplasia. 20:69–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rubinsztein DC: The roles of intracellular
protein-degradation pathways in neurodegeneration. Nature.
443:780–786. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu X, Feng X, Zhao X, Ma F, Liu N, Guo H,
Li C, Du H and Zhang B: Role of beclin-1-mediated autophagy in the
survival of pediatric leukemia cells. Cell Physiol Biochem.
39:1827–1836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu G, Pei F, Yang F, Li L, Amin AD, Liu
S, Buchan JR and Cho WC: Role of autophagy and apoptosis in
non-small-cell lung cancer. Int J Mol Sci. 18:E3672017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Behl C: Breaking BAG: The Co-Chaperone
BAG3 in health and disease. Trends Pharmacol Sci. 37:672–688. 2017.
View Article : Google Scholar
|
|
17
|
Takayama S, Xie Z and Reed JC: An
evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone
regulators. J Biol Chem. 274:781–786. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rauch JN, Tse E, Freilich R, Mok SA,
Makley LN, Southworth DR and Gestwicki JE: Bag3 is a modular,
scaffolding protein that physically links heat shock protein 70
(Hsp70) to the small heat shock proteins. J Mol Biol. 429:128–141.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Knezevic T, Myers VD, Gordon J, Tilley DG,
Sharp TE III, Wang J, Khalili K, Cheung JY and Feldman AM: BAG3: A
new player in the heart failure paradigm. Heart Fail Rev.
20:423–434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ganassi M, Mateju D, Bigi I, Mediani L,
Poser I, Lee HO, Seguin SJ, Morelli FF, Vinet J, Leo G, et al: A
surveillance function of the HSPB8-BAG3-HSP70 chaperone complex
ensures stress granule integrity and dynamism. Mol Cell.
63:796–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Felzen V, Hiebel C, Koziollek-Drechsler I,
Reißig S, Wolfrum U, Kögel D, Brandts C, Behl C and Morawe T:
Estrogen receptor alpha regulates non-canonical autophagy that
provides stress resistance to neuroblastoma and breast cancer cells
and involves BAG3 function. Cell Death Dis. 6:e18122015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim EM, Jung CH, Kim J, Hwang SG, Park JK
and Um HD: The p53/p21 complex regulates cancer cell invasion and
apoptosis by targeting Bcl-2 family proteins. Cancer Res.
77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen G, Ke Z, Xu M, Liao M, Wang X, Qi Y,
Zhang T, Frank JA, Bower KA, Shi X and Luo J: Autophagy is a
protective response to ethanol neurotoxicity. Autophagy.
8:1577–1589. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ylä-Anttila P, Vihinen H, Jokitalo E and
Eskelinen EL: Monitoring autophagy by electron microscopy in
mammalian cells. Methods Enzymol. 452:143–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan B, Chen D, Huang J, Wang R, Feng B,
Song H and Chen L: HMGB1-mediated autophagy promotes docetaxel
resistance in human lung adenocarcinoma. Mol Cancer. 13:1652014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee SW, Kim HK, Lee NH, Yi HY, Kim HS,
Hong SH, Hong YK and Joe YA: The synergistic effect of combination
temozolomide and chloroquine treatment is dependent on autophagy
formation and p53 status in glioma cells. Cancer Lett. 360:195–204.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Damia G and Broggini M: Platinum
resistance in ovarian cancer: Role of DNA repair. Cancer (Basel).
11:E1192019. View Article : Google Scholar
|
|
29
|
Bookman MA: First-line chemotherapy in
epithelial ovarian cancer. Clin Obstet Gynecol. 55:96–113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahmad L, Mostowy S and Sancho-Shimizu V:
Autophagy-virus interplay: From cell biology to human disease.
Front Cell Dev Biol. 6:1552018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen N and Karantza V: Autophagy as a
therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He C, Dong X, Zhai B, Jiang X, Dong D, Li
B, Jiang H, Xu S and Sun X: MiR-21 mediates sorafenib resistance of
hepatocellular carcinoma cells by inhibiting autophagy via the
PTEN/Akt pathway. Oncotarget. 30:28867–28881. 2015.
|
|
33
|
Xiao L, Shi XY, Zhang Y, Zhu Y, Zhu L,
Tian W, Zhu BK and Wei ZL: YAP induces cisplatin resistance through
activation of autophagy in human ovarian carcinoma cells. Onco
Ther. 9:1105–1114. 2016.
|
|
34
|
Zhang SF, Wang XY, Fu ZQ, Peng QH, Zhang
JY, Ye F, Fu YF, Zhou CY, Lu WG, Cheng XD and Xie X: TXNDC17
promotes paclitaxel resistance via inducing autophagy in ovarian
cancer. Autophagy. 11:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y, Jiang W, Hu Y, Da Z, Zeng C, Tu M,
Deng Z and Xiao W: MicroRNA-199a-5p inhibits cisplatin-induced drug
resistance via inhibition of autophagy in osteosarcoma cells. Oncol
Lett. 12:4203–4208. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin WM and Li ZG: Blockage of
cisplatin-induced autophagy sensitizes cervical cancer cells to
cisplatin. Gene Mol Res. 14:16905–16912. 2015. View Article : Google Scholar
|
|
37
|
De Marco M, Basile A, Iorio V, Festa M,
Falco A, Ranieri B, Pascale M, Sala G, Remodelli P, Capunzo M, et
al: Role of BAG3 in cancer progression: A therapeutic opportunity.
Semin Cell Dev Biol. 78:85–92. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nymoen DA, Hetland Falkenthal TE, Holth A,
Ow GS, Ivshina AV, Tropé CG, Kuznetsov VA, Staff AC and Davidson B:
Expression and clinical role of chemoresponse-associated genes in
ovarian serous carcinoma. Gynecol Oncol. 139:30–39. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Suzuki M, Iwasaki M, Sugio A, Hishiya A,
Tanaka R, Endo T, Takayama S and Saito T: BAG3 (BCL2-associated
athanogene 3) interacts with MMP-2 to positively regulate invasion
by ovarian carcinoma cells. Cancer Lett. 303:65–71. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Habata S, Iwasaki M, Sugio A, Suzuki M,
Tamate M, Satohisa S, Tanaka R and Saito T: BAG3 increases the
invasiveness of uterine corpus carcinoma cells by suppressing
miR-29b and enhancing MMP2 expression. Oncol Rep. 33:2613–2621.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Habata S, Iwasaki M, Sugio A, Suzuki M,
Tamate M, Satohisa S, Tanaka R and Saito T: BAG3-mediated Mcl-1
stabilization contributes to drug resistance via interaction with
USP9X in ovarian cancer. Int J Oncol. 49:402–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu K, Yang Y, Zhao J and Zhao S:
BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and
enhance apoptosis of human esophageal carcinoma cells by targeting
the drug transporter ABCC10. Cancer Lett. 371:125–133. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Belaid A, Ndiaye PD, Filippakis H, Roux J,
Röttinger É, Graba Y, Brest P, Hofman P and Mograbi B: Autophagy:
Moving benchside promises to patient bedsides. Curr Cancer Drug
Targets. 15:684–702. 2015. View Article : Google Scholar : PubMed/NCBI
|
